7 completed, 3 unknown, 1 recruiting, 1 terminated. 6 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Unknown 2 |
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Malignant Neoplasm of Stomach: new trials by email Literature Review of Malignant Neoplasm of Stomach trials Research Report on Malignant Neoplasm of Stomach
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Radiation for Abdominopelvic Metastases Adaptive Stereotactic Body Radiation - Neoplasm - Soft Tissue Pelvis Malignant Secondary, Malignant Neoplasm of Stomach | Phase 1 | Recruiting | Fox Chase Cancer Center | 30 | 2023-08-01 | 2025-10-29 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer D2 radical gastrectomy, SOX neoadjuvant or postoperative chemotherapy, Hyperthermic intraperitoneal chemotherapy (HIPEC) - Malignant Neoplasm of Stomach | Phase 2 | Unknown | Wuhan University | 100 | 2020-04-01 | 2020-04-14 |
| Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer Hyperthermic intraperitoneal chemotherapy (HIPEC), D2 radical gastrectomy, SOX postoperative chemotherapy - Malignant Neoplasm of Stomach | Phase 2 | Completed | Wuhan University | 100 | 2015-08-01 | 2020-03-24 |
| Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma Cisplatin, 5-fluorouracil or Capecitabine, Trastuzumab - Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 172 | 2015-07-15 | 2025-07-31 |
| Radical Gastrectomy With/Without HIPEC in Advanced Gastric Cancer Patients intraperitoneal chemoperfusion - Malignant Neoplasm of Stomach | Phase 3 | Unknown | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 60 | 2015-01-01 | 2015-03-06 |
| Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography Pulmonary Disease, Postoperative Respiratory Complications | Completed | Johannes Gutenberg University Mainz | 130 | 2014-05-01 | 2023-09-29 | |
| Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis HIPEC - Malignant Neoplasm of Stomach, Secondary Malignant Neoplasm of Peritoneum | Phase 3 | Completed | Charite University, Berlin, Germany | 105 | 2014-03-01 | 2021-07-29 |
| Surgicel® Fibrillar for Delayed Bleeding After ESD PPI, H2RA and surgicel - Benign Neoplasm of Stomach, Malignant Neoplasm of Stomach | Not applicable | Completed | Soonchunhyang University Hospital | 146 | 2012-12-01 | 2014-05-13 |
| Screening for Familial Gastric Cancer in First Degree Relatives Endoscopy with staining of the mucosa - Malignant Neoplasm of Stomach, Carcinoma, Diffuse Type | Not applicable | Terminated | Radboud University Medical Center | 79 | 2012-11-01 | 2019-09-16 |
| Early Recovery After Gastric Cancer Surgery Early recovery - Fasting, Malignant Neoplasm of Stomach | Phase 2 | Unknown | Ajou University School of Medicine | 109 | 2012-07-01 | 2012-07-20 |
| MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma Oxaliplatin, Folinic Acid, 5-fluoro-uracil - Malignant Neoplasm of Esophagus, Malignant Neoplasm of Stomach | Phase 2 | Completed | UNICANCER | 162 | 2011-01-01 | 2020-11-17 |
| Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE Capecitabine/Cisplatin + Sorafenib, Capecitabine/Cisplatin - Malignant Neoplasm of Stomach, Effects of Chemotherapy | Phase 2 | Completed | Asan Medical Center | 195 | 2010-08-01 | 2020-01-07 |
Stomach Neoplasms (12) · Adenocarcinoma (1) · Airway Obstruction (1) · Carcinoma (1) · Esophageal Neoplasms (1) · Fasting (1) · Hypoxia (1) · Liver Diseases (1) · Lung Diseases (1) · Pancreatic Diseases (1) · Peritoneal Neoplasms (1) · Pleural Effusion (1) · Pneumonia (1) · Pneumothorax (1) · Pulmonary Atelectasis (1)
Digestive System Diseases (12) · Digestive System Neoplasms (12) · Gastrointestinal Diseases (12) · Gastrointestinal Neoplasms (12) · Neoplasms (12) · Neoplasms by Site (12) · Stomach Diseases (12) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Abdominal Neoplasms (1) · Behavior (1) · Carcinoma (1) · Esophageal Diseases (1) · Feeding Behavior (1) · Head and Neck Neoplasms (1)
Hyperthermic Intraperitoneal Chemotherapy (4) · Capecitabine (2) · Cisplatin (2) · Drug Therapy (1) · Endoscopy (1) · Fluorouracil (1) · Gastrectomy (1) · Leucovorin (1) · Oxaliplatin (1) · Panitumumab (1) · Sorafenib (1) · Surgical Procedures, Operative (1) · Surgicel (1) · Trastuzumab (1) · pertuzumab (1)
Wuhan University (2) · Ajou University School of Medicine (1) · Asan Medical Center (1) · Charite University, Berlin, Germany (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Fox Chase Cancer Center (1) · Johannes Gutenberg University Mainz (1) · Radboud University Medical Center (1) · Soonchunhyang University Hospital (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1) · UNICANCER (1)
South Korea (4) · China (3) · Germany (3) · France (2) · Netherlands (2) · Belgium (1) · Estonia (1) · Italy (1) · Norway (1) · Portugal (1) · Singapore (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Anna Dorothea Wagner, MD (1) · Beate Rau, Prof. (1) · Fokko M Nagengast, M.D.Ph.D. (1)
PMID 27486629, PMID 31126258, PMID 31930513, PMID 37906724
2009 (1), 2014 (1)